Call for Sessions Now Closed
Thank you to those who submitted thoughtful proposals to help shape the 2026 program. The ideas received reflect the most pressing challenges and emerging themes across medtech — and will inform a dynamic, cross-cutting agenda in Boston.
Our Program Committee will now begin the review process, carefully evaluating submissions and shaping a world-class program for October 18–21, 2026. The conversations that change our industry don’t just happen at The MedTech Conference — they start here. Hear from the program team on why The MedTech Conference is where industry defining conversations happen each year.
Ready to Get Started?
We’ve organized a quick guide to streamline your submission process. We highly recommend utilizing this guide to thoughtfully draft your responses and perfect your proposal before submission.
- Review the Call for Sessions Procedures and Guidelines
- Download the Session Proposal Template for efficient proposal planning
- Review the FAQ section below
Thank you to everyone who submitted session proposals for this year’s MedTech Conference. Our program committee will now start the exciting journey of reviewing your submissions. Please mark your calendars, as submitters will receive notification regarding proposal decisions on Friday, May 17th. We look forward to the opportunity to showcase your work and thank you once again for your participation during this process.
There are plenty of opportunities to be involved in this year’s conference. Explore how your company can get prime visibility at #medtechcon, October 15-17, 2024. Be sure to sign up to receive exciting news and announcements about the event.
Explore the Program Tracks
Covers the medtech industry’s current performance, investment and M&A trends, strategic partnerships, and key policy decisions driving success in medtech. The content of these sessions is relevant for emerging and established company executives, corporate and business development leaders, medtech investors (angels, family offices, VCs, and private equity), investment banks, and others in the financial community.
Dedicated to exploring the transformative impact of digital innovations in the medical technology sector. Attendees can expect a focused exploration of how cutting-edge digital technologies are reshaping patient care, improving outcomes, and driving advancements in the medtech landscape.
Examines issues important to the industry’s early and emerging innovators and key trends shaping the sector. Past sessions have offered practical insights on commercialization strategies for small companies, building effective teams through strong boards and governance, and navigating product development and clinical milestones that support fundraising. The track also addresses factors influencing investment and innovation, including strategic partnerships and alternative funding sources. Overall, it provides a focused, high-value look at the companies and ideas driving the next wave of medtech growth.
Prioritizes conversations on a health care system that promotes optimal health outcomes for all patients and includes conversation regarding the need for a more inclusive workforce to design and develop the products that patients receive.
Addresses global perspectives, challenges, and opportunities within the medical technology sector. Covers insights into navigating the complexities of operating in diverse international markets, understanding regulatory landscapes, and fostering cross-border partnerships. Whether you’re an international business executive, a policymaker, or a global health expert, this track provides a platform to explore the interconnected nature of the medtech industry on a global scale.
Explores the cutting-edge technologies shaping the landscape of diagnostic medicine by bringing together clinicians, researchers, and industry professionals. Attendees can expect robust discussions aiming to foster diagnostics innovations, embrace scientific advances, and ensure swift access to accurate and reliable tests for all patients.
Provides valuable insights into the legal intricacies shaping the medtech sector by gathering legal professionals, compliance experts, and industry leaders and executives. Sessions provide in-depth discussions on navigating complex legal landscapes, maintaining regulatory compliance, and understanding the legal implications of innovations in medtech.
Examines the dynamics of bringing medical technologies to market, securing payment mechanisms, and optimizing health care delivery. Industry leaders, policy makers, payers, and health care professionals discuss the complexities of market access, understanding payment structures, and leveraging innovative approaches to enhance the overall delivery of health care services.
Discusses the development and implementation of technological initiatives and tools aimed at actively involving patients in their health care journey; leveraging medtech to create strategies, applications, platforms, and systems that enhance patient empowerment and overall participation in their care.
Explores the unique challenges and opportunities in bringing pediatric medical technologies to market. Sessions spotlight regulatory pathways, clinical trial strategies, and commercialization models tailored to small patient populations, helping innovators, clinicians, and investors advance solutions that improve care for pediatric populations.
Focuses on the regulatory and quality aspects shaping medtech for those involved in regulatory affairs, quality management, or manufacturing. Attendees can expect in-depth discussions including FDA and industry leaders on navigating regulatory landscapes, ensuring product quality and safety, and implementing robust manufacturing processes.
Analyzes the intricate web of activities involved in the production, distribution, and management of medical technology products. Supply chain professionals and industry experts will explore topics such as logistics, procurement, inventory management, and the integration of advanced technologies in supply chain processes.
Hear from Some of our Past Speakers
FAQs
Friday February 20, 2026, at 11:59 pm PT. Extensions are not granted.
Friday, May 15, 2026. Submitters will receive an email from [email protected].
The MedTech Conference program proposal process is highly competitive. The Program Committee will review hundreds of proposals to select approximately 45 – 55 total panel sessions.
More information about The MedTech Conference tracks can be reviewed here. We are particularly interested in cross-cutting sessions that resonate with multiple audience types and/or sessions that speak to high-level/executive-level audiences. Additional resources:
The MedTech Conference 2025 program
The MedTech Conference 2025 attendee demographics
The proposal submitter will serve as the primary point of contact for all communication from AdvaMed regarding the status of the submission. Should the session be accepted, an alternative individual may assume the role of Session Organizer.
Each organization may submit up to four (4) proposals. Please make every effort to communicate internally within your organization regarding the number of proposals being submitted.
AdvaMed encourages elements of audience engagement including but not limited to: Q&A, polling, video, etc. Please describe your session format in detail in your proposal.
All sessions should include more than one (1) speaker and no more than four (4) speakers.
Other than relevant government agencies (FDA, CMS), no more than one (1) speaker from the same organization should be proposed. Proposals with multiple speakers from the same organization will not score favorably.
Proposals absent speaker details (name/title/company) will not score favorably. It is important that the speakers proposed can be reasonably confirmed by the session organizer should the session be selected. If you do not know your proposed speakers’ contact information, please provide as much information as possible. Note: AdvaMed does not share speaker contact information submitted through the Call for Sessions.
Informal communication with potential speakers is acceptable; however, speaker confirmation is contingent upon receiving feedback from AdvaMed should your proposal be accepted by the Program Committee. Until you receive notification that your session has been accepted/additional instructions from AdvaMed, please do not invite your proposed speakers.